Hopefully Starpharma will find a partner for its viral conjunctivitis eye drops so it can be developed and brought to market....alongside taking on Dep Gemcitabine and licensing it out to big pharma to develop
Fyi
The US Patent and Trademark Office have granted Starpharma a patent for SPL7013 ophthalmic drops for viral conjunctivitis.
The patent has been granted with broad claims for treating and preventing microbial infections of the eye and the patent term is to 2033.
SPL7013 is a proprietary dendrimer which is the active ingredient in Starpharma’s VivaGel® products. SPL7013 ophthalmic drops have already demonstrated compelling efficacy in animal models of viral conjunctivitis.
The drops have shown potent anti-viral activity, decreased infectivity and are non-irritating.
Starpharma recently completed independent market research with US Physicians / Ophthalmologists and Payers regarding the opportunity for SPL7013 ophthalmic drops. Findings from the research were extremely positive and have been of particular interest in discussions with potential partners.
Viral conjunctivitis is the most common cause of infectious conjunctivitis, affecting approximately 6 million people in the US and approximately 4 million in Europe each year.
The viral conjunctivitis market is estimated to be around US$700 million annually.
There are currently no approved therapies for viral conjunctivitis and it remains an area of significant unmet medical need globally.
So looks like we have a solution to more than a AUD $1 billion market
- Forums
- ASX - By Stock
- SPL
- Dawn of a new era come Monday 8th of January
Dawn of a new era come Monday 8th of January, page-2
-
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.9¢ |
Change
0.001(1.02%) |
Mkt cap ! $40.41M |
Open | High | Low | Value | Volume |
9.5¢ | 9.9¢ | 9.5¢ | $6.492K | 66.35K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 16735 | 9.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 57241 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 16944 | 0.099 |
2 | 20102 | 0.098 |
1 | 6185 | 0.097 |
2 | 528090 | 0.095 |
3 | 40638 | 0.094 |
Price($) | Vol. | No. |
---|---|---|
0.100 | 57307 | 5 |
0.105 | 143452 | 5 |
0.110 | 114609 | 7 |
0.115 | 77331 | 6 |
0.120 | 89055 | 5 |
Last trade - 14.59pm 11/07/2024 (20 minute delay) ? |
Featured News
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
HCH
Hot Chili sets up water company as drought racks Chile–but must also build communities a desal plant
SPL (ASX) Chart |